Ali MohamedVice President, CMC at Immatics, USA
Ali Mohamed, PhD, Vice President, CMC, Immatics US Inc in Houston TX currently leading the development and manufacturing of various Adoptive Cell Therapies. Dr. Mohamed has more than 20 years of experience in process development and GMP manufacturing of regenerative medicine, cell and gene therapy products at various CMOs and clinical stage companies. Before joining Immatics, Dr. Mohamed was the senior director of manufacturing operations/ manufacturing development at PCT (Hitachi Chemical Advanced Therapeutics Solutions) helping various companies manufacture cell in gene therapy products.
Dr. Mohamed holds a PhD in Molecular Pharmacology from Medical College of Ohio (Currently the University of Toledo Medical College) and postdoctoral fellowship in neuroscience and neurobiology from the Georgetown University Institute of Cognitive and Computational Sciences.